Comparison of two optimization algorithms (VOLO
CyberKnife®
SBRT
SRS
optimization algorithm
Journal
Journal of applied clinical medical physics
ISSN: 1526-9914
Titre abrégé: J Appl Clin Med Phys
Pays: United States
ID NLM: 101089176
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
revised:
15
07
2023
received:
17
03
2023
accepted:
14
08
2023
medline:
4
12
2023
pubmed:
6
9
2023
entrez:
6
9
2023
Statut:
ppublish
Résumé
Two optimization algorithms VOLO™ and sequential optimization algorithm (SEQU) are compared in the Precision® treatment planning system from Accuray® for stereotactic radiosurgery and stereotactic body radiotherapy (SBRT) treatment plans. The aim is to compare the two algorithms to assess if VOLO™ is better of SEQU in certain treatment site. Sixty clinical treatment cases were compared. Entities include Acoustic neuroma (AN), lung metastases, and liver metastases. In each entity, 10 SEQU and 10 VOLO™ treatment plans were optimized. The Ray-Tracing calculation algorithm was used for all treatment plans and the treatments were planned exclusively with fixed cones (5-50 mm). The number of nodes, beams, total MU, and treatment time were compared. Conformity index (CI), new conformity index (nCI), homogeneity index (HI), gradient index (GI), and target coverage were examined for agreement. D AN treatment plans showed significant differences for the number of nodes, beams, total MU, treatment time, D98%, D100% for the target volume, and the doses for all organs at risk. VOLO™ achieved better results on average. Total MU, treatment time, coverage, and D98% are significantly better for VOLO™ for lung metastases. For liver metastases, a significant reduction in number of nodes, total MU, and treatment time was observed for VOLO™ plans. The mean target coverage increased slightly with VOLO™, while the mean CI deteriorated slightly. The averages of D The results of the present study indicate that VOLO™ should be used in place of SEQU as a standard for AN cases moving forward. Despite the lack of significance in the lung and liver cases, VOLO™ optimization is recommended because OAR sparing was similar, but coverage, D
Identifiants
pubmed: 37672349
doi: 10.1002/acm2.14144
pmc: PMC10691623
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14144Informations de copyright
© 2023 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine.
Références
Int J Radiat Oncol Biol Phys. 2001 Dec 1;51(5):1313-9
pubmed: 11728692
J Appl Clin Med Phys. 2011 Feb 08;12(2):3368
pubmed: 21587185
Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1177-81
pubmed: 12654424
Neurosurgery. 2007 Feb;60(2 Suppl 1):ONS147-56; discussion ONS156
pubmed: 17297377
Med Phys. 2012 Apr;39(4):1877-86
pubmed: 22482609
J Appl Clin Med Phys. 2023 Dec;24(12):e14144
pubmed: 37672349
J Med Phys. 2016 Apr-Jun;41(2):135-43
pubmed: 27217626
Phys Med. 2020 Mar;71:31-38
pubmed: 32088563
Med Phys. 2010 Aug;37(8):4078-101
pubmed: 20879569
Technol Cancer Res Treat. 2008 Oct;7(5):369-74
pubmed: 18783286
Med Phys. 2016 May;43(5):2063
pubmed: 27147318
Med Phys. 2008 May;35(5):2094-103
pubmed: 18561685
Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):277-84
pubmed: 20004530
Strahlenther Onkol. 2014 Oct;190(10):872-81
pubmed: 25091267
Semin Radiat Oncol. 2008 Oct;18(4):215-22
pubmed: 18725106
Phys Med Biol. 2009 Sep 21;54(18):5359-80
pubmed: 19687567
J Neurosurg. 2006 Dec;105 Suppl:194-201
pubmed: 18503356
Phys Med. 2019 Aug;64:230-237
pubmed: 31515024
Med Phys. 1998 Aug;25(8):1424-34
pubmed: 9725129
Cancer Radiother. 2006 Sep;10(5):283-7
pubmed: 16859948
Acta Oncol. 2006;45(7):831-7
pubmed: 16982547
Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1409-19
pubmed: 12654454
J Appl Clin Med Phys. 2020 May;21(5):38-47
pubmed: 32212374